A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer

Published:2013-08 Issue:8 Volume:8 Page:1091-1094
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

de Marinis Filippo,Atmaca Akin,Tiseo Marcello,Giuffreda Libero,Rossi Antonio,Gebbia Vittorio,Antonio Chiara D’,Zotto Laura Dal,Al-Batran Salah-Eddin,Marsoni Silvia,Wolf Martin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Chemotherapy for small cell lung cancer;Sandler;Semin Oncol,2003

2. A review of first-line treatment for small cell lung cancer;Murray;J Thorac Oncol,2006

3. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up;Sundstrøm;J Clin Oncol,2002

4. Systematic Review of topotecan (Hycamtin) in relapsed small cell lung cancer;Riemsma;BMC Cancer,2010

5. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer;von Pawel;J Clin Oncol,1999

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs;Cancer Letters;2024-09

2. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

3. Research Status of Anti-Aging Drugs in Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024

4. Novel Therapeutic Options for Small Cell Lung Cancer;Current Oncology Reports;2023-10-23

5. Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses;Biomedicine & Pharmacotherapy;2023-08